Gabriela Trevisan Selected Research

2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamide

7/2021	Role of TRPA1 expressed in bone tissue and the antinociceptive effect of the TRPA1 antagonist repeated administration in a breast cancer pain model.
5/2020	Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation.
2/2020	Topical transient receptor potential ankyrin 1 antagonist treatment attenuates nociception and inflammation in an ultraviolet B radiation-induced burn model in mice.
1/2020	TRPA1 activation mediates nociception behaviors in a mouse model of relapsing-remitting experimental autoimmune encephalomyelitis.
1/2019	Transient receptor potential ankyrin 1 (TRPA1) plays a critical role in a mouse model of cancer pain.
12/2018	Topical treatment with a transient receptor potential ankyrin 1 (TRPA1) antagonist reduced nociception and inflammation in a thermal lesion model in rats.
1/2016	TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress.
1/2015	The involvement of the TRPA1 receptor in a mouse model of sympathetically maintained neuropathic pain.
5/2013	Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriela Trevisan Research Topics

Disease

43	Pain (Aches) 01/2022 - 11/2008
36	Hyperalgesia 01/2022 - 02/2011
19	Neuralgia (Stump Neuralgia) 01/2022 - 11/2008
17	Edema (Dropsy) 12/2020 - 12/2010
17	Inflammation (Inflammations) 12/2020 - 01/2013
13	Neoplasms (Cancer) 03/2022 - 05/2013
11	Chronic Pain 01/2022 - 02/2011
11	Hypersensitivity (Allergy) 05/2020 - 05/2013
8	Cancer Pain 08/2021 - 09/2013
7	Gout 05/2022 - 08/2011
6	Acute Pain 07/2019 - 04/2009
5	Breast Neoplasms (Breast Cancer) 07/2021 - 12/2014
5	Peripheral Nervous System Diseases (PNS Diseases) 02/2019 - 05/2013
4	Melanoma (Melanoma, Malignant) 03/2022 - 01/2016
4	Multiple Sclerosis 01/2022 - 05/2020
4	Sunburn 12/2020 - 04/2014
4	Postoperative Pain 12/2020 - 12/2011
3	Arthritis (Polyarthritis) 05/2022 - 11/2013
3	Migraine Disorders (Migraine) 01/2022 - 12/2013
3	Headache (Headaches) 01/2022 - 08/2021
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 05/2020
3	Constipation 12/2020 - 10/2013
3	Burns 03/2020 - 12/2018
3	Ischemia 01/2020 - 05/2014
3	Contact Dermatitis (Eczema, Contact) 03/2019 - 01/2019
3	Neurogenic Inflammation 12/2014 - 12/2010
2	Intractable Pain 01/2022 - 01/2017
2	Cold Hypersensitivity 12/2020 - 01/2015
2	Neuroinflammatory Diseases 01/2020 - 12/2017
2	Wounds and Injuries (Trauma) 07/2019 - 12/2017
2	Surgical Wound 11/2017 - 10/2013

Drug/Important Bio-Agent (IBA)

24	AnkyrinsIBA 01/2022 - 08/2013
9	AntioxidantsIBA 01/2022 - 02/2011
9	Analgesics (Analgesic Drugs)IBA 01/2022 - 11/2008
9	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 07/2021 - 05/2013
9	Pharmaceutical PreparationsIBA 12/2020 - 11/2008
8	Freund's AdjuvantIBA 05/2020 - 02/2011
8	Paclitaxel (Taxol)FDA LinkGeneric 04/2020 - 12/2013
8	Capsaicin (Zostrix)FDA Link 07/2019 - 08/2011
7	Thioctic Acid (Lipoic Acid)IBA 01/2022 - 05/2013
7	Peptides (Polypeptides)IBA 01/2022 - 09/2013
7	TRPA1 Cation ChannelIBA 08/2021 - 05/2014
7	Opioid Analgesics (Opioids)IBA 08/2021 - 09/2013
6	Uric Acid (Urate)IBA 05/2022 - 08/2011
6	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019 - 11/2013
5	Morphine (MS Contin)FDA LinkGeneric 12/2020 - 09/2013
5	Irritants (Vesicants)IBA 03/2019 - 08/2013
5	Complex MixturesIBA 03/2019 - 01/2013
4	Calcitonin Gene-Related PeptideIBA 01/2022 - 12/2010
4	CytokinesIBA 01/2022 - 01/2019
4	VenomsIBA 01/2022 - 09/2013
4	Proteins (Proteins, Gene)FDA Link 11/2021 - 04/2014
4	Ion Channels (Ion Channel)IBA 08/2021 - 12/2018
3	ziconotide (Prialt)FDA Link 01/2022 - 11/2008
3	Calcium Channels (Calcium Channel)IBA 01/2022 - 12/2013
3	resiniferatoxinIBA 08/2021 - 06/2018
3	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2020 - 12/2018
3	Peroxidase (Myeloperoxidase)IBA 12/2020 - 03/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 04/2014
3	Antisense OligonucleotidesIBA 05/2020 - 01/2019
3	acetovanillone (apocynin)IBA 05/2020 - 01/2016
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2020 - 11/2008
3	CalciumIBA 02/2020 - 02/2011
3	spinasterolIBA 01/2020 - 11/2012
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020 - 01/2019
3	allyl isothiocyanateIBA 01/2020 - 05/2013
3	Croton OilIBA 03/2019 - 01/2019
3	Dexamethasone (Maxidex)FDA LinkGeneric 03/2019 - 01/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2016 - 01/2012
2	A 967079IBA 05/2020 - 01/2019
2	CationsIBA 02/2020 - 01/2019
2	Clodronic Acid (Clodronate)IBA 01/2020 - 01/2016
2	prostaglandin-inositol cyclic phosphateIBA 01/2020 - 09/2019
2	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2019 - 12/2010
2	cinnamaldehyde (cinnamic aldehyde)FDA Link 03/2019 - 07/2014
2	Methylene Chloride (Dichloromethane)IBA 01/2019 - 11/2012
2	ethyl acetateIBA 01/2019 - 10/2013
2	EnzymesIBA 01/2019 - 01/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2017 - 01/2016
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2017 - 01/2016
2	KininsIBA 12/2017 - 01/2016
2	Acetic Acid (Vinegar)FDA LinkGeneric 11/2017 - 01/2014
2	Cholinergic Agents (Cholinergics)IBA 10/2017 - 10/2013
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 03/2013
2	InterleukinsIBA 01/2016 - 07/2014
2	NeuropeptidesIBA 12/2014 - 12/2010
2	CarrageenanIBA 07/2014 - 01/2014
2	TRPV1 receptorIBA 02/2014 - 02/2011
2	Conotoxins (Conotoxin)IBA 12/2013 - 09/2013
2	Histamine (Histamine Dihydrochloride)FDA Link 12/2011 - 08/2011

Therapy/Procedure

8	Therapeutics 12/2020 - 12/2011
6	Drug Therapy (Chemotherapy) 08/2021 - 05/2013
6	Ligation 12/2017 - 10/2013
5	Analgesia 12/2020 - 11/2008
4	Oral Administration 12/2017 - 10/2013
3	Aftercare (After-Treatment) 03/2022 - 01/2013
2	Spinal Injections 04/2020 - 01/2016
2	Intra-Articular Injections 01/2020 - 01/2016
2	Complementary Therapies (Alternative Medicine) 07/2018 - 01/2016
2	Traditional Medicine (Folk Remedies) 10/2013 - 01/2013